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Abstract
Background: T cells play a central role in many inflammatory diseases, hence the identification
and validation of T cell-specific target genes will increase the understanding of T cell function in
pathologic inflammatory situations. RNA interference (RNAi), with its ability to induce specific gene
silencing in mammalian cells, represents a powerful technology to investigate and validate the
function of pharmaceutical target genes in vitro and in vivo. The aim of the present study was to
systematically explore RNAi-mediated gene-silencing of known T cell-specific model signaling
molecules in primary murine T cells in vitro and in vivo.
Results: We demonstrate that siRNA delivery and subsequent silencing of T cell specific genes is
substantially increased, if murine T cells were activated prior siRNA transfection. Silencing of
ZAP70, p56Lck as well as PLC-γ1 protein expression resulted in impaired function of T cells in vitro.
Furthermore, delayed type hypersensitivity (DTH) was ameliorated in vivo after adoptive transfer
of ZAP70-silenced T cells.
Coclusion: The combination of RNAi-mediated gene silencing and adoptive transfer of gene-
silenced T cells, thus, may allow the identification and analysis of T cell-specific targets for
therapeutic intervention. Additionally, this model system may represent an alternative to
conventional time consuming and cost intensive gene targeting approaches.
Background
RNAi is a naturally occurring mechanism of gene regula-
tion conserved in plants and mammalian cells. The mech-
anism of RNAi was identified and characterized almost a
decade ago in the nematode worm Caenorhabditis elegans
[1]. It relies on double-stranded (ds), small interfering
RNAs (siRNAs) of 21–23 nucleotides that induce
sequence-specific gene silencing in mammalian cells [2].
siRNAs derive from long dsRNAs that trigger the RNAi
machinery and are cleaved by the RNaseIII-like enzyme
Dicer [3]. siRNAs are incorporated into the RNA-induced
silencing complex (RISC) that comprises helicase, exonu-
clease, and homology-searching domains. The siRNA
duplex is unwound and the antisense strand mediates
mRNA recognition and thereby, mRNA degradation and
subsequent gene silencing. Over the last few years, RNAi
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has evolved as a new technology for specific gene knock-
down that allows analysis of gene function in vitro and in
vivo and the identification of new molecular targets asso-
ciated with disease, such as cancer and inflammation [4-
7].
T cells constitute one of the major components of the
adaptive, cellular immune system. They play a pivotal role
in the onset, balance and maintenance of immune
responses as well as autoimmunity. Adaptive immune
responses are initiated by interactions of T cells with anti-
gen-presenting cells (APC), such as dendritic cells, in the
secondary lymphoid organs. T cells become activated and
develop into effector cells by a series of activation signals
consisting of i) antigen presentation by APC via peptide-
major histocompatibility (MHC) complexes that stimu-
late the T-cell receptor (TCR, [6]), ii) costimulation by B7
family members that bind to CD28 expressed on T cells
[7]. Upon engagement of the TCR, a signaling cascade
inside the cell is initiated that leads to activation of the T
cell. The Src family of protein tyrosine kinases Fyn and Lck
become activated and phosphorylate the cytoplasmic
domains of the CD3 complex which then interact with the
zeta-chain-associated protein kinase 70 (ZAP70). ZAP70
is subsequently phosphorylated by p56Lck and Fyn and
stimulates downstream signaling events leading to the
recruitment and activation of a number of other signaling
proteins, such as phospholipase C gamma (PLC-γ;[8,9].
Before the discovery of RNAi, studies of gene function
mainly relied on knockout strains, protein overexpression
and protein-protein interaction assays. However, the
knockout of genes results in a complete lack of gene ontol-
ogy and can cause embryonic lethality or induce compen-
satory mechanisms. Protein overexpression may result in
non physiological conditions and thereby lead to incor-
rect interpretation of gene function. Whereas successful
RNAi in human T cells has been documented in literature
[10,11], primary murine T cells are difficult to transfect
and therefore published data desribing an efficient pro-
tein knockdown in mouse T cells are scarce [12,13].
Here, we report a systematic analysis of RNAi-mediated
gene modulation for model target genes in primary
murine T cells. We investigated the transfection of siRNA
molecules into primary murine T cells in vitro and tested
such gene-silenced T cells in an adoptive cell transfer
model of DTH based on Ovalbumin (OVA) TCR-trans-
genic T cells in vivo. Efficient siRNA delivery and subse-
quent silencing of ZAP70 protein expression strongly
depended on T cell activation. ZAP70-silenced T cells dis-
played impaired function in vitro as well as in vivo by
inducing less DTH than cells transfected with control
siRNA. The combination of RNAi in murine T cells and
the in vivo analysis of gene-silenced T cells by adoptive
transfer may represent a powerful technique to identify
and validate novel signaling pathways and inflammation-
relevant target genes in T cell biology.
Methods
Mice
Eight-12 weeks old BALB/c mice were purchased from
Charles River Laboratories (Sulzfeld, Germany). Age- and
sex-matched DO11.10 mice were kindly provided by C.
Doebis (Deutsches Rheumaforschungszentrum, Berlin,
Germany). T cells of DO11.10 mice express a transgenic
TCR recognizing OVA323–339 peptide bound to I-Ad [14].
All animal experiments were performed in accordance
with institutional, state, and federal guidelines.
Generation of T cells and Th1 cells
T cells of BALB/c mice were isolated from splenocytes by
immunomagnetic bead purification using the mouse Pan
T cell isolation kit according to the manufacturer's instruc-
tions (Miltenyi Biotec, Bergisch Gladbach, Germany).
Th1 cells were generated in vitro from lymph node cells
and splenocytes of DO11.10 mice. Single cell suspensions
of splenocytes and lymph node cells were prepared and
erythrocytes lysed with 0.83% NH4Cl. Cell concentration
was adjusted to 2 × 106 cells/ml and lymph node cells
were co-cultured with splenocytes at a ratio of 1:2.5 in 6-
well plates. Cells were grown in VLE-RPMI 1640 medium
with stable glutamine (Biochrom, Berlin, Germany) con-
taining 10% heat-inactivated FCS, 50 μM β-mercaptoeth-
anol (Sigma, Germany), 100 U/ml penicillin and 100 μg/
ml streptomycin sulfate (Invitrogen, Karlsruhe, Ger-
many). Recombinant mouse IFNγ (20 ng/ml), IL-12 (10
ng/ml, both R&D systems) and OVA323–339 peptide (1 μg/
ml; synthesized at the Department of Biochemistry, Hum-
boldt University, Berlin, Germany) were added to the cul-
ture. After 3 days of culture, cells were used for
transfection with siRNA and cultured for another 72 h to
allow for knockdown of mRNA and protein expression.
72 h after transfection, cells were used for adoptive cell
transfer.
Restimulation
Transfected BALB/c T cells or Th1 cells were restimulated
either with plate-bound anti-mouse CD3ε antibody (10
μg/ml; clone 145-2C11, BD Biosciences, Heidelberg, Ger-
many) or with PMA (25 ng/ml, Sigma, Germany) and ion-
omycin (1 μg/ml, Sigma, Germany). Supernatant was
removed 24 h later and analyzed for the secretion of the
cytokines interleukin-2 (IL-2) and interferon gamma
(IFN-γ) by ELISA (eBioscience, San Diego, USA). For 3H-
thymidine incorporation cells were pulsed with 0.5 μCi
3H-thymidine/well (Amersham Biosciences, GE Health-
care, Munich, Germany) at day 3 of culture. Cells were
harvested 6 hours later and 3H-thymidine incorporationCell Communication and Signaling 2008, 6:3 http://www.biosignaling.com/content/6/1/3
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was measured in a Microbeta Counter (Wallac, Turku, Fin-
land).
Transfection
After 3 days, 2 × 107 Th1 cells of DO11.10 mice and/or
anti-mouse CD3-stimulated T cells or lymph node cells of
BALB/c mice were transfected by nucleofection using the
mouse T cell Nucleofector kit and the corresponding
transfection programme for murine T cells from AMAXA
(Cologne, Germany). Cells were transfected with func-
tional, non-targeting control siRNA (siControl, non-tar-
geting siRNA pool, Dharmacon, Lafayette, USA), a siRNA
pool consisting of four siRNAs specific for ZAP710, Lck or
PLC-γ1 (siGENOME SMART pool, Dharmacon, Lafayette,
USA) or three individual ZAP70-specific Stealth™ siRNAs
(Invitrogen, Karlsruhe, Germany). The targeted sequence
of the ZAP70-specific stealth™ siRNAs are as follows:
stealth™ siRNA #1:
5'UCUCGUACACACUUGUGUCCAUGGG3', stealth™
siRNA #2: 5'AAUUAGUCCAUCGCGCUUCAGCUUC3',
stealth™ siRNA #3: 5'
UUGUCUGUCGAUGACGCUAAGGCUG3'. Briefly, cells
were transfected with different amounts of siRNA and cul-
tured in complete medium and 12-well plates for up to 72
h for subsequent analysis or adoptive cell transfer. Trans-
fection efficiency for GFP plasmid DNA yielded 30% of
GFP-positive cells under the applied conditions The trans-
fection effiency with siRNAs was 70–80% determined
with fluorescently-labeled siRNAs. Viability of murine T
cells transfected by nucleofection was 40–50%.
RNA isolation, cDNA synthesis and RT-PCR
For the detection of mRNA knockdown by RT-PCR 1 × 106
transfected cells were lysed with Nucleic Acid Purification
Lysis solution (Applied Biosystems, Darmstadt, Germany)
and mRNA was isolated using a ABI Prism™ 6100 Nucleic
Acid PrepStation (Applied Biosystems, Darmstadt, Ger-
many). cDNA synthesis of RNA samples was performed
with TaqMan® Reverse Transcription Reagents (Applied
Biosystems, Darmstadt, Germany). Samples were incu-
bated for 10 min at room temperature, 30 min at 48°C
and 5 min at 95°C. Subsequent RT-PCR was performed in
triplicates for each gene using TaqMan® Gene Expression
Assays specific for Lck (Mm 00802897_m1), PLC-γ1 (Mm
01247275_m1), ZAP70 (Mm00494255_m1) and β-actin
(Mm00607939_s1, all Applied Biosystems, Darmstadt,
Germany) and following the manufacturer's protocol The
reactions were run on the GeneAmp® PCR System 9700
thermal cycler with the following amplification program:
50°C for 2 min, 95°C for 10 min, followed by 40 cycles
of 95°C for 15 s, 60°C for 1 min. Data was analyzed using
Sequence Detection Systems Software v2.2.1 (Applied
Biosystems, Darmstadt, Germany) and the gene of interest
was normalized to the corresponding β-actin results.
Protein isolation and Western blot analysis
Protein expression of siRNA-transfected cells was ana-
lyzed by Western blot analysis. At least 2 × 106 cells were
lysed in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 2 mM EGTA, 1 mM NAF, 1% Triton X-100, 1 mM
sodium orthovanadate + complete protease inhibitor
cocktail tablets (Roche, Mannheim, Germany)). 5 μg of
protein lysate determined by BCA Protein Assay Kit
(Pierce, Bonn, Germany) and were separated on 10%
SDS-PAGE gels and blotted onto PVDF membranes (Bio-
rad, Munich, Germany). Proteins were identified using
anti-Lck, (clone 3A5, Millipore, Schwalbach, Germany),
anti-PLC-γ1 (clone D-7-3, Millipore, Schwalbach, Ger-
many), anti-ZAP70 (clone 4H386, USBiological, Massa-
chusetts, USA) and anti-β-actin (clone AC-74, Sigma-
Aldrich, Schnelldorf, Germany) antibodies. As secondary
antibody HRP-conjugated IgG sheep anti-mouse polyclo-
nal serum (GE Healthcare, Munich, Germany) was used
and developed with ECL reagents (ECL kit, Amersham
Biosciences, GE Healthcare, UK).
Th1-mediated DTH model
The Th1-mediated DTH model was performed as
described before [15] with minor modifications. Briefly, a
total of 1 × 106  transfected Th1 cells generated from
DO11.10 mice were injected intravenously into the tail
veins of naïve BALB/c mice. Adoptively transferred cells
were either mock transfected, transfected with a control
siRNA pool or with ZAP70-specific siRNA. 24 h after
adoptive cell transfer, the DTH response was induced by
subcutaneous injection of 250 ng OVA323–339  peptide
together with incomplete Freund's adjuvant (IFA) into the
right footpad. As control, the left footpad was injected s.c.
with PBS/IFA. 24 h after antigen injection, footpad thick-
ness was determined as parameter for the inflammatory
response using a specialized micrometer (Bayer Schering
Pharma AG, Berlin). Experimental research on animals
followed internationally recognized guidelines and was
approved by government authorities in Berlin.
Statistics
Data are presented as mean ± SD. Significance was deter-
mined by Mann-Whitney U test. Differences were consid-
ered statistically significant with p ≤ 0.05 and highly
significant with p ≤ 0.01.
Results
Stimulation of murine T cells is required to reduce ZAP70 
protein expression via RNAi
To investigate whether T cell activation improves transfec-
tion efficiency and thereby RNAi-mediated knockdown of
ZAP70 in murine T cells, T cells from Balb/c mice were
stimulated with anti-mouse CD3ε-specific antibody or
left untreated for 24 h. Stimulated and unstimulated cells
were transfected with control siRNA or ZAP70-specificCell Communication and Signaling 2008, 6:3 http://www.biosignaling.com/content/6/1/3
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siRNA pool by nucleofection and ZAP70 silencing was
determined in the cell lysates by RT-PCR and Western blot
analysis (Fig. 1). In the unstimulated T cells, mRNA
expression of ZAP70 was reduced 48 h and 72 h after
nucleofection. Reduced quantities of ZAP70-specific
mRNA, however, did not translate into a knockdown of
ZAP70 protein (Fig. 1B, note the stronger β-actin signal in
the unstimulated ZAP70 probe at 72 hours). In contrast to
the unstimulated cells, mRNA and protein silencing of
ZAP70 was already detectable in the stimulated cell frac-
tion 24 h after transfection and this was maintained until
72 hours post transfection. The observed correlation of T
cell activation and efficient protein knockdown in the case
of ZAP70 gene expression, was extended by RNAi studies
employing p56Lck and PLC-γ1 as model targets. Here
again, stimulation of murine T cells was a prerequisite for
successful RNAi-mediated gene silencing (Fig. 2 and data
not shown). Hence, T cell receptor-triggered activation
seems to be an important prerequisite for efficient RNAi-
mediated modulation of protein expression in murine T
cells.
Modified siRNAs allow efficient silencing of ZAP70
Next, we tested the efficiency of unmodified and chemi-
cally modified ZAP70-specific siRNAs to induce ZAP70
RNA and protein knockdown. Stimulated T cells were
transfected with the previously used ZAP70-specific
siRNA pool or three individual stealth™ siRNAs. ZAP70
Stimulation is required to silence ZAP70 expression in T  cells Figure 1
Stimulation is required to silence ZAP70 expression 
in T cells. Murine T cells were stimulated ("+", anti-mouse 
CD3ε) or left untreated ("-"). 24 h later, cells were trans-
fected with 0.9 μM ZAP70-specific siRNA pool by nucleofec-
tion. Cell lysates were prepared 24, 48 and 72 h after 
transfection and ZAP70 expression was analyzed by RT-PCR 
(A) and Western blot analysis (B). As control, cells were 
mock ("-", no siRNA added) transfected () or cells were 
transfected with a control siRNA pool (Ctrl). (A) RT-PCR of 
ZAP70 mRNA expression determined as fold expression of 
the house keeping gene β-actin. (B) Western blot analysis of 
ZAP70 was detected by ZAP70-specific antibody. β-actin was 
used as loading control. Shown are the mean values of tripli-
cates of a representative experiments of four independent 
experiments.
Modified siRNAs allow efficient silencing of ZAP70 silencing  mRNA and protein Figure 2
Modified siRNAs allow efficient silencing of ZAP70 
silencing mRNA and protein. Stimulated murine T cells 
were transfected with 0.9 μM ZAP70-specific siRNA pool 
(Pool) or three different stealth™ siRNAs (S#1, S#2, and 
S#3) by using nucleofection. Cell lysates were prepared 24 
and 48 h after transfection and ZAP70 expression was ana-
lyzed by RT-PCR (A) and Western blot analysis (B). As con-
trol cells were mock transfected ("-", no siRNA added), or 
transfected with a control siRNA pool (Ctrl). (A) RT-PCR of 
ZAP70 mRNA expression in transfected T cells determined 
24 h after nucleofection as fold expression of the house 
keeping gene β-actin. (B) Western blot analysis of transfected 
T cells 48 h after nucleofection with siRNAs indicated in (A). 
Protein knockdown of ZAP70 was detected by ZAP70-spe-
cific antibody. β-actin was used as loading control. Shown are 
the mean values of triplicates of a representative experi-
ments of two independent experiments.Cell Communication and Signaling 2008, 6:3 http://www.biosignaling.com/content/6/1/3
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knockdown was analyzed in the cell lysates by RT-PCR
and Western blot 24 and 48 h after nucleofection (Fig. 2).
As in previous experiments, the siRNA pool efficiently
silenced ZAP70 mRNA and protein expression. Stealth™
siRNA #1 was potent in reducing ZAP70 mRNA and pro-
tein expression, whereas stealth™ siRNA # 2 and 3 were
less potent as indicated by the RT-PCR and Western blot
results. These results demonstrate that our initial findings
employing pools of siRNAs can be reproduced with
mono-specific, chemically modified siRNAs.
RNAi is applicable for signaling proteins involved in T cell 
activation
After successful silencing of ZAP70 mRNA and protein
expression in murine T cells, we tested RNAi to modulate
protein expression of additional, again well-characterized,
key molecules involved in T cell signaling. To this end we
selected p56Lck and PLC-γ1 for further analysis. Mouse T
cells were activated and subsequently transfected with a
siRNA control pool or siRNA pools specific for p56Lck,
PLC-γ, or ZAP70. Transfection with specific siRNAs
strongly reduced ZAP70 mRNA expression in activated T
cells to background levels, while transfection with both
p56Lck and PLC-γ siRNA pools reduced mRNA expression
by 75% (Fig. 3). The results of Western blot analysis cor-
related well with the RT-PCR results: ZAP70 protein
expression under the experimental conditions was sub-
stantially reduced, whereas p56Lck and PLC-γ proteins
were still present in the transfected T cells although at
reduced levels as detected in Western blot.
RNAi of T cell-specific signaling molecules alters murine T 
cell function in vitro
The effect of RNAi-induced p56Lck, PLC-γ and ZAP70 pro-
tein knockdown on T cell function was further investi-
gated in vitro quantifying the proliferation and cytokine
release of siRNA-treated T cells. Previously activated T
cells, transfected with p56Lck, PLC-γ1 or ZAP70 siRNAs,
were incubated for 3 days and then restimulated by TCR-
specific (anti-CD3 antibody) or TCR-independent (PMA
and ionomycin) treatment. IL-2 and IFN-γ secretion and
proliferation were determined by ELISA and 3H-thymi-
dine incorporation, respectively (Table 1). Both, cytokine
production and cell proliferation, were clearly reduced in
T cells transfected with p56Lck-, PLC-γ1 or ZAP70-specific
siRNAs, when the T cells were activated via the TCR. RNAi
of the tested genes specifically interfered with TCR-
dependent pathways and does not exert its function via
non-specific, e.g. toxic transfection-related mechanisms,
since all transfected T cells equally well responded to PMA
and ionomycin stimulation. Hence, using the described
experimental setup, i.e. activation of T cells and nucleofec-
tion, RNAi allows specific loss-of-function studies in pri-
mary murine T cells in vitro.
RNAi of ZAP70 alters murine T cell function in vivo
In order to analyze murine T cells in vivo, we used T cells
from DO11.10 TCR-transgenic T cells, which allows the
induction and tracing of an immune response with
defined antigen specificity in vitro and in vivo. Since in our
hands the RNAi-mediated protein knockdown was most
efficient for the T cell-specific ZAP70 as model gene, acti-
vated DO11.10 T cells transfected with ZAP70 specific siR-
NAs were first functionally analyzed by in vitro
restimulation. Transfection of DO11.10 T cells with
ZAP70-specific siRNAs, as shown before for non TCR-
transgenic murine T cells (Table 1), resulted in substan-
tially reduced IL-2 secretion after CD3-mediated stimula-
tion (Fig. 4A). Subsequently, ZAP70-silenced T cells were
further investigated in an adoptive cell transfer model of
RNAi is applicable for signaling proteins involved in T cell  activation Figure 3
RNAi is applicable for signaling proteins involved in T 
cell activation. Stimulated murine T cells were transfected 
with 0.9 μM ZAP70-, PLC-γ- or Lck-specific siRNA pool by 
using nucleofection. Cell lysates were prepared 24 and 48 h 
after transfection and mRNA and protein expression were 
analyzed by RT-PCR (A) and Western blot analysis (B). As 
control, cells were transfected with a control siRNA pool 
(Ctrl). (A) RT-PCR results of transfected T cells determined 
24 h after nucleofection with Control ("siCtrl"), ZAP70 
("siZAP70"), PLC-γ ("siPLC-γ1") and Lck ("siLck") specific 
siRNAs. (B) Western blot analysis of transfected T cells 48 h 
after nucleofection. Protein knockdown of ZAP70, PLC-γ 
and Lck was detected by specific antibodies. β-actin was used 
as loading control. Shown are the mean values of triplicates 
of a representative experiments of two independent experi-
ments.Cell Communication and Signaling 2008, 6:3 http://www.biosignaling.com/content/6/1/3
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DTH (Fig. 4B). Adoptive transfer of transfected DO11.10
T cells into Balb/c mice, elicited a significantly (p ≤ 0.001)
reduced DTH response in the recipient mice compared to
T cells transfected with control siRNA. Our results show
that RNAi-mediated modulation of T cell function can
also be exploited in inflammatory model systems in vivo.
Discussion
The present study describes the application of RNAi tech-
nology in primary murine T cells and for the first time its
successful application in an adoptive cell transfer model
of DTH in vivo.
In our hands, activation of murine T cells was a prerequi-
site for successful RNAi-mediated knockdown. This has
not been described in detail before (Choi et al., 2006;
Chung et al., 2007) and may be specific for the nucleofec-
tion transfection technology we employed in combina-
tion with our cells of interest – murine T cells. For optimal
RNAi-induced protein knockdown several factors like cel-
lular uptake, half-life of the target mRNA (and the pro-
tein), and the structure and accessibility of the target
mRNA need to be considered [16-18]. Possibly, activation
of murine T cells improves the accessibility of the target
mRNA and/or structure as well as transfection efficiency.
Using GFP reporter constructs (data not shown), we could
demonstrate that in activated and transfected murine T
cells a higher percentage of the T cells was GFP-positive
when compared to naïve, unstimulated murine T cells.
Our data demonstrate that knockdown efficiency can dif-
fer between the genes of interest and are in line with data
describing that sequence, structure, half-life and turnover
rate of the target mRNA need to be considered for success-
ful RNAi-based modulation of protein expression
[4,5,19]. The investigations presented in this study inten-
tionally focussed on known model proteins being critical
for TCR-mediated signaling events during T cell activation
in order to have a clear phenotypic readout, e.g. reduced
cytokine secretion, in the silenced cells. We clearly show
that an efficient siRNA-mediated knockdown of p56Lck,
PLC-γ1 and ZAP70 is possible in activated murine T cells
with the consequence that the siRNA-treated T cells exhib-
ited an altered functional phenotype regarding cytokine
secretion and proliferation. Having optimized the experi-
mental conditions for siRNA delivery into murine T cells,
our results may be extended to other relevant molecules
expressed in T cells in future investigations.
Recently, RNAi technology also facilitated more detailed
investigations on the role of kinases in TCR-mediated sig-
naling using in vitro activated T cells or T cell lines [20-22].
Here, we describe the impact of a kinase knockdown
(ZAP70)  in vivo by an adoptive cell transfer model of
DTH. This adoptive cell transfer model offers the unique
advantage to evaluate the role of target genes in its corre-
sponding in vivo environment of inflammation. Loss-of-
function studies by RNAi and adoptive cell transfer may,
thus, represent a new method to study direct correlations
between gene expression and the function of the respec-
tive protein in an inflammatory response. Murine in vivo
models rely mainly on transgenic and knockout strains.
However, gene targeting in mice can, on one hand, cause
embryonic lethality or on the other hand, in the case of
transgenic expression, lead to non-physiological protein
expression. Although the number of elegant inducible
knockout strains is constantly increasing, experiments
employing these mouse strains are time consuming and
cost-intensive. Here, we show that under defined experi-
mental conditions, i.e. pre-activation of the T cells, RNAi
technology represents a powerful tool to validate T cell
specific genes in murine T cells, which can subsequently
Table 1: Proliferation, IL-2 and IFN-γ production of stimulated and siRNA-transfected BALB/c T cells.
siRNA IL-2 [pg/ml] IFN-γ [pg/ml] Proliferation [CPM]
αCD3
Ctrl 1417 ± 144 965 ± 105 4106 ± 433
Lck 443 ± 93 357 ± 50 540 ± 220
PLC-γ 195 ± 28 146 ± 26 236 ± 19
ZAP70 400 ± 60 467 ± 149 568 ± 69
PMA + Ionomycin
Ctrl 1980 ± 2 5067 ± 346 19919 ± 787
Lck 2167 ± 0 4158 ± 135 16640 ± 954
PLC-γ 1676 ± 28 2939 ± 88 11285 ± 658
ZAP70 1991 ± 2 4603 ± 277 15987 ± 1906
T cells were transfected with 0.9 μM Lck-, PLC-γ- and ZAP70-specific siRNA pool, ZAP70-specific stealth™ siRNA 1 and with control siRNA pool 
(Ctrl). 72 h after nucleofection, functionality of transfected cells was tested by restimulation with anti-mouse CD3 antibody or PMA and ionomycin 
in vitro. IL-2 and IFN-γ production was determined in the supernatant 24 h after restimulation by ELISA. Means of duplicate values are shown. 
Proliferation of T cells was detected by 3H-thymidine incorporation 96 h after restimulation. Values of 3H-thymidine incorporation are shown in 
means of triplicates.Cell Communication and Signaling 2008, 6:3 http://www.biosignaling.com/content/6/1/3
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be used in established in vivo animal models to better
understand the regulation and contribution of inflamma-
tion-relevant genes.
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RNAi-mediated knockdown of ZAP70 affects T cell function  in vitro and in vivo Figure 4
RNAi-mediated knockdown of ZAP70 affects T cell 
function in vitro and in vivo. DO11.10 T cells were either 
mock transfected, transfected with a control siRNA pool 
(Ctrl), or transfected with 0.9 μM ZAP70-specific stealth™ 
siRNA #1 (ZAP70). 72 h after nucleofection, functionality of 
transfected cells was tested by restimulation (α-CD3) in vitro 
or by adoptive cell transfer into naïve recipient mice in vivo. 
(A) 1 × 106 DO11.10 T cells were restimulated with 3 or 10 
μg/ml anti-mouse CD3 antibody. IL-2 production was deter-
mined in the supernatants by ELISA. Means of duplicate val-
ues are shown.(B) 1 × 106 transfected Th1 cells were 
adoptively transferred via i.v. injection into Balb/c mice. Cells 
were either mock transfected, transfected with a control 
siRNA pool or with ZAP70-specific siRNA. 24 h after adop-
tive cell transfer, DTH response in the footpad was induced 
by s.c. injection of OVA peptide/IFA in recipients of cells 
transfected with control or ZAP70-specific siRNA. As con-
trol, recipient mice having obtained mock transfected cells 
were challenged with PBS/IFA. Footpad thickness was deter-
mined 24 h after antigen exposure. (*** p ≤ 0.001). Shown is 
the mean value of 20 mice in total (per group) analyzed in 
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